Konsyl Pharmaceuticals Inc

As a world leader in auto-injector technology, Meridian Medical Technologies, a King Pharmaceutical company, offers a broad range of auto-injector drug delivery systems and drug formulations for emergency medical use. Each auto-injector is a pre-filled, self-contained, pressure-activated device designed for the quick administration of a precise dose of medication. Unlike a syringe, which can be cumbersome and time-consuming, Meridian s auto-injectors provide a compact, quick and portable delivery system. The design s simplicity, concealed needle and speed of injection render these auto-injectors ideal for self or caregiver. Since the 1960s, the company has partnered with and served as a critical supplier for the United States Department of Defense. Meridian is the only supplier of FDA-approved auto-injectors containing nerve agent antidotes and has produced in excess of 185 million auto-injectors for the world market.

DENTSPLY Caulk is a division of DENTSPLY International, which is a global designer, developer, manufacturer and supplier of a wide range of products for the dental market. Its business has three segments that includes dental consumables, dental laboratory products and specialty dental products. DENTSPLY Caulk provides a variety of dental products, such as impression materials, adhesives, cements, bridges and crowns, direct restoratives, and finishing and polishing products. It sells its products under various brand names, including Reprosil, Polyjel, Jeltrate, Hydrosil, Massad, Rim-Lock, First Bite, FluoroCore, Integrity, Calibra and Tylok. The company also provides dental anesthetics, prophylaxis pastes, tooth whiteners and topical fluorides. DENTSPLY Caulk is located in Milford, Del.

Lupin Pharmaceuticals specializes in the design and development of a variety of generic medicines. Operational since 2003, the company s facilities are approved by the Food and Drug Administration. It develops and markets a range of drugs for children under the Suprax brand. The company maintains more than 10 manufacturing facilities in the United States. Lupin Pharmaceuticals is a wholly owned subsidiary of Lupin Limited, which is one of the leading pharmaceutical companies in India. With annual revenues of over $690 million, Lupin Limited maintains a research and development center in Pune in India. The company specializes in the development of drugs for the treatment of diabetes.